May is designated as Skin Cancer Awareness/Prevention Month. It aims to raise awareness of the public to take proactive steps to protect their skin and detect skin cancer early.

To further discuss research related to Skin Cancer Awareness/Prevention Month, Dermatopathology (ISSN: 2296-3529) has brought together a collection of open access academic research studies on the topic of skin cancer. We would like to use this special day to share new scientific knowledge in the field of skin cancer Awareness/Prevention Month with the world.

1. “Aggressive Cutaneous Squamous Cell Carcinomas Following Treatment for Graft-versus-Host Disease: A Case Report and Review of Risk Factors”
by Gehan A. Pendlebury, Michelle A. Bongiorno and Jeffrey N. Lackey
Dermatopathology 2022, 9(2), 122–130; https://doi.org/10.3390/dermatopathology9020015
Available online: https://www.mdpi.com/2296-3529/9/2/15

2. “An Up-to-Date Correlation of Epidemiological and Histopathological Characteristics of Basal Cell Carcinoma of the Skin in a County Hospital in Romania”
by Iuliu Gabriel Cocuz, Maria Elena Cocuz, Adrian-Horațiu Sabău, Raluca Niculescu, Andreea Cătălina Tinca, Vlad Vunvulea, Corina Eugenia Budin, Mihaela Cornelia Șincu, Maria Cătălina Popelea and Ovidiu Simion Cotoi
Dermatopathology 2022, 9(2), 183–195; https://doi.org/10.3390/dermatopathology9020023
Available online: https://www.mdpi.com/2296-3529/9/2/23

3. “Endocrine Mucin-Producing Sweat Gland Carcinoma: Case Presentation with a Comprehensive Review of the Literature”
by Gerardo Cazzato, Emilio Bellitti, Irma Trilli, Anna Colagrande, Nicoletta Sgarro, Vincenza Sara Scarcella, Teresa Lettini, Giuseppe Ingravallo, Domenico Piscitelli, Leonardo Resta et al.
Dermatopathology 2023, 10(3), 266–280; https://doi.org/10.3390/dermatopathology10030035
Available online: https://www.mdpi.com/2296-3529/10/3/35

4. “Histopathological Diagnosis of Malignant Melanoma at the Dawn of 2023: Knowledge Gained and New Challenges”
by Gerardo Cazzato
Dermatopathology 2023, 10(1), 91–92; https://doi.org/10.3390/dermatopathology10010013
Available online: https://www.mdpi.com/2296-3529/10/1/13

5. “PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma”
by Valerie Glutsch, Marion Wobser, Bastian Schilling, Anja Gesierich, Matthias Goebeler and Hermann Kneitz
Dermatopathology 2022, 9(2), 148–157; https://doi.org/10.3390/dermatopathology9020019
Available online: https://www.mdpi.com/2296-3529/9/2/19

6. “Clinical and Histopathologic Profile of Patients with Cutaneous Metastasis in a Tertiary Hospital in the Philippines”
by Jolene Kristine Gatmaitan Dumlao, Eileen Liesl A. Cubillan and Juan Paolo David S. Villena
Dermatopathology 2022, 9(4), 392–407; https://doi.org/10.3390/dermatopathology9040046
Available online: https://www.mdpi.com/2296-3529/9/4/46

7. “Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls”
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008
Available online: https://www.mdpi.com/2296-3529/10/1/8

8. “Not Your Mother’s Melanoma: Causes and Effects of Early Melanoma Diagnosis”
by Kaviyon Sadrolashrafi and David Graham Cotter
Dermatopathology 2022, 9(4), 368–378; https://doi.org/10.3390/dermatopathology9040043
Available online: https://www.mdpi.com/2296-3529/9/4/43

9. “Folliculotropic Mycosis Fungoides Is Associated with Decreased PD1 Staining Compared with Classic Mycosis Fungoides”
by Haiming Tang, Kristin J. Rybski, Yi Luan and Bruce R. Smoller
Dermatopathology 2023, 10(4), 303–309; https://doi.org/10.3390/dermatopathology10040038
Available online: https://www.mdpi.com/2296-3529/10/4/38